new HIV drug, Selzentry (maraviroc)

September 2007

You'll hear about a new HIV drug, Selzentry (maraviroc).

It's the first in a new class called CCR5 antagonists.

These bind to a receptor called CCR5 on white blood cells...to keep the HIV virus from entering the cell.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote